These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 35164127)

  • 21. Evaluation of Matrix Tablets Based on Eudragit®E100/Carbopol®971P Combinations for Controlled Release and Improved Compaction Properties of Water Soluble Model Drug Paracetamol.
    Obeidat WM; Nokhodchi A; Alkhatib H
    AAPS PharmSciTech; 2015 Oct; 16(5):1169-79. PubMed ID: 25724162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of Eudragit RS-PO and Ethocel 100 matrices for the controlled release of lobenzarit disodium.
    Boza A; Caraballo I; Alvarez-Fuentes J; Rabasco AM
    Drug Dev Ind Pharm; 1999 Feb; 25(2):229-33. PubMed ID: 10065357
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Formulation and assessment of controlled release tablets of famotidine by using eudragit RL 100 polymer.
    Rabani T; Umer Jan S; Razaque G; Gul R; Ahmad Khan K; Rashid F; Tufail M
    Pak J Pharm Sci; 2022 Nov; 35(6(Special)):1779-1786. PubMed ID: 36861243
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanistic Approach to Understanding the Influence of USP Apparatus I and II on Dissolution Kinetics of Tablets with Different Operating Release Mechanisms.
    Lu Z; Fassihi R
    AAPS PharmSciTech; 2017 Feb; 18(2):462-472. PubMed ID: 27106916
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interpolymer complexation between copovidone and carbopol and its effect on drug release from matrix tablets.
    Zhang F; Meng F; Wang ZY; Na W
    Drug Dev Ind Pharm; 2017 Feb; 43(2):190-203. PubMed ID: 27599027
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The influence of polymer content on early gel-layer formation in HPMC matrices: The use of CLSM visualisation to identify the percolation threshold.
    Mason LM; Campiñez MD; Pygall SR; Burley JC; Gupta P; Storey DE; Caraballo I; Melia CD
    Eur J Pharm Biopharm; 2015 Aug; 94():485-92. PubMed ID: 26143369
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Formulation and evaluation of time-controlled triple-concentric mefenamic acid tablets for rheumatoid arthritis.
    Patel P; Madan P; Lin S
    Pharm Dev Technol; 2014 May; 19(3):355-62. PubMed ID: 23611159
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Investigating the in vitro drug release kinetics from controlled release diclofenac potassium-ethocel matrix tablets and the influence of co-excipients on drug release patterns.
    Shah SU; Shah KU; Rehman A; Khan GM
    Pak J Pharm Sci; 2011 Apr; 24(2):183-92. PubMed ID: 21454168
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Swellable matrices for the controlled-release of diclofenac sodium: formulation and in vitro studies.
    Bravo SA; Lamas MC; Salomon CJ
    Pharm Dev Technol; 2004; 9(1):75-83. PubMed ID: 15000468
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development and evaluation of natural gum-based extended release matrix tablets of two model drugs of different water solubilities by direct compression.
    Ofori-Kwakye K; Mfoafo KA; Kipo SL; Kuntworbe N; Boakye-Gyasi ME
    Saudi Pharm J; 2016 Jan; 24(1):82-91. PubMed ID: 26903772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Formulation and in vitro evaluation of ibuprofen-Carbopol 974P-NF controlled release matrix tablets. III: Influence of co-excipients on release rate of the drug.
    Khan GM; Jiabi Z
    J Control Release; 1998 Jul; 54(2):185-90. PubMed ID: 9724905
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro Evaluation of the Effect of Combination of Hydrophilic and Hydrophobic Polymers on Controlled Release Zidovudine Matrix Tablets.
    Ganesh S; Radhakrishnan M; Ravi M; Prasannakumar B; Kalyani J
    Indian J Pharm Sci; 2008; 70(4):461-5. PubMed ID: 20046771
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preparation and characterization of pH-independent sustained release tablet containing solid dispersion granules of a poorly water-soluble drug.
    Tran HT; Park JB; Hong KH; Choi HG; Han HK; Lee J; Oh KT; Lee BJ
    Int J Pharm; 2011 Aug; 415(1-2):83-8. PubMed ID: 21641985
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of binary mixtures consisting of cross-linked high amylose starch and hydroxypropylmethylcellulose used in the preparation of controlled release tablets.
    Rahmouni M; Lenaerts V; Massuelle D; Doelker E; Johnson M; Leroux JC
    Pharm Dev Technol; 2003; 8(4):335-48. PubMed ID: 14601958
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro release testing of matrices based on starch-methyl methacrylate copolymers: effect of tablet crushing force, dissolution medium pH and stirring rate.
    Ferrero C; Jiménez-Castellanos MR
    Int J Pharm; 2014 Jan; 461(1-2):270-9. PubMed ID: 24333902
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of Carbopol 71G-NF on the release of dextromethorphan hydrobromide from extended-release matrix tablets.
    Fayed MH; Mahrous GM; Ibrahim MA; Sakr A
    Pharm Dev Technol; 2013; 18(5):971-81. PubMed ID: 21639691
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In-vitro studies of diclofenac sodium controlled-release from biopolymeric hydrophilic matrices.
    Bravo SA; Lamas MC; Salamón CJ
    J Pharm Pharm Sci; 2002; 5(3):213-9. PubMed ID: 12553888
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Formulation and evaluation of non-effervescent floating tablets of losartan potassium.
    Getyala A; Gangadharappa HV; Prasad MS; Reddy MP; Kumar TM
    Curr Drug Deliv; 2013 Oct; 10(5):620-9. PubMed ID: 23286884
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro release of ketoprofen from hydrophilic matrix tablets containing cellulose polymer mixtures.
    Vueba ML; Batista de Carvalho LA; Veiga F; Sousa JJ; Pina ME
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1651-62. PubMed ID: 23094867
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Controlled release matrix tablets of zidovudine: effect of formulation variables on the in vitro drug release kinetics.
    Ravi PR; Kotreka UK; Saha RN
    AAPS PharmSciTech; 2008; 9(1):302-13. PubMed ID: 18446496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.